Sugammadex Piramal यूरोपीय संघ - जर्मन - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neuromuskuläre blockade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Sugammadex Mylan यूरोपीय संघ - जर्मन - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neuromuskuläre blockade - alle anderen therapeutischen produkte - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Juta 100 mg/ml Injektionslösung जर्मनी - जर्मन - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

sugammadex juta 100 mg/ml injektionslösung

"juta" pharma gmbh (8010239) - sugammadex-natrium - injektionslösung - 100 mg/ml - sugammadex-natrium (33574) 108,8 milligramm

Sugammadex Reddy 100 mg/ml Injektionslösung बेल्जियम - जर्मन - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sugammadex reddy 100 mg/ml injektionslösung

reddy holding - sugammadex sodium - injektionslösung - 100 mg/ml - sugammadex sodium 108.8 mg/ml - sugammadex

Sugammadex Fresenius Kabi यूरोपीय संघ - जर्मन - EMA (European Medicines Agency)

sugammadex fresenius kabi

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskuläre blockade - alle anderen therapeutischen produkte - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Amomed यूरोपीय संघ - जर्मन - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskuläre blockade - alle anderen therapeutischen produkte - umkehrung der neuromuskulären blockade durch rocuronium oder vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.